Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72244, first published .
Association of Modifiable Lifestyle and Metabolic Factors With the Risk of Developing Sepsis: 2-Sample Mendelian Randomized Study

Association of Modifiable Lifestyle and Metabolic Factors With the Risk of Developing Sepsis: 2-Sample Mendelian Randomized Study

Association of Modifiable Lifestyle and Metabolic Factors With the Risk of Developing Sepsis: 2-Sample Mendelian Randomized Study

1Department of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

2Department of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China

3State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, No.79 Qingchun Road, Shangcheng District, Zhejiang Province, Hangzhou, China

4Yuhang Institute for Collaborative Innovation and Translational Research in Life Sciences and Technology, Hangzhou, China

*these authors contributed equally

Corresponding Author:

Kaijin Xu


Background: Sepsis is a life-threatening condition characterized by organ dysfunction resulting from dysregulated host response to infections. Approximately 48.9 million people worldwide are diagnosed with sepsis annually, leading to 11 million deaths and representing 19.7% of all global deaths. No specific, effective treatments for sepsis, which has a poor prognosis, are available.

Objective: The study aimed to systematically explore the association between genetically predicted modifiable risk factors and sepsis.

Methods: Univariable 2-sample Mendelian randomization (MR) analysis was performed to explore the association between 30 modifiable risk factors (12 lifestyle, 3 educational and psychological, and 15 metabolic factors) and sepsis. Heterogeneity was evaluated using the Cochran Q analysis. Sensitivity analyses were conducted using the MR-Egger regression intercept tests and leave-one-out analyses. Additionally, multivariable MR analyses were performed to adjust for genetic associations between the instruments and obesity.

Results: Genetically predicted smoking (odds ratio [OR] 1.20, 95% CI 1.06‐1.36; P=.005), a higher number of cigarettes smoked daily (OR 1.70, 95% CI 1.29‐2.23; P<.001), a higher overall health rating (OR 2.19, 95% CI 1.61‐2.98; P<.001), BMI (OR 1.50, 95% CI 1.38‐1.63; P<.001), waist circumference (OR 1.70, 95% CI 1.53‐1.89; P<.001), whole body fat mass (OR 1.50, 95% CI 1.37‐1.64; P<.001), trunk fat mass (OR 1.48, 95% CI 1.36‐1.62; P<.001), arm fat mass (OR 1.57, 95% CI 1.43‐1.71; P<.001), and leg fat mass (OR 1.69, 95% CI 1.51‐1.90; P<.001) were associated with increased sepsis risk. However, light physical activity (OR 0.26, 95% CI 0.08‐0.83; P=.03), higher education attainment (OR 0.52, 95% CI 0.40‐0.67; P<.001), and high-density lipoprotein cholesterol (OR 0.91, 95% CI 0.84‐0.98; P=.02) exhibited protective effects against sepsis. Using a multivariate analysis of obesity traits, the waist circumference (OR 2.16, 95% CI 1.18‐3.96; P=.01) was an independent risk factor of sepsis.

Conclusions: Our study demonstrated that genetic predictors of lifestyle (smoking and physical activity), educational level, and metabolic factors (waist circumference and high-density lipoprotein cholesterol) exhibited a causal association with sepsis risk. Future research should further investigate the underlying mechanisms of these associations to inform more effective preventive strategies against sepsis.

Interact J Med Res 2025;14:e72244

doi:10.2196/72244

Keywords



Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infections [1]. Epidemiological studies indicate that approximately 48.9 million people worldwide were diagnosed with sepsis annually, leading to 11 million deaths and representing 19.7% of all global deaths [2]. In China, sepsis affects 20% of patients in intensive care units, with a 90-day mortality rate of 35.5% [3]. The substantial epidemiological burden underscores the critical importance of sepsis as a public health issue [4]. Despite decades of research, current therapies remain limited to organ support and antimicrobial interventions, without any targeted treatment available [5-7]. These limited therapeutic options highlight the urgent need for shifting focus toward modifiable risk factors for prevention. The World Health Organization 2020 Sepsis Report specifically highlights vulnerable populations and health care seekers, while outlining future research directions and priorities in sepsis epidemiology. Although sepsis manifests diversely and can be life-threatening, it remains preventable and reversible [4].

Host risk factors for sepsis are multifaceted, encompassing extremes of age, immunosuppression, and comorbidities [8,9]. Emerging evidence suggests that socioeconomic determinants (eg, education level and occupation) and metabolic disorders (eg, obesity and diabetes) may influence susceptibility to sepsis [10-16]. However, the existing observational studies report inconsistent conclusions. For instance, although lower socioeconomic status is broadly linked to higher sepsis incidence [10,11], another study paradoxically found no association using adjusted models [17]. Metabolic comorbidities further illustrate this ambiguity. Although obesity is widely implicated in sepsis risk [18], some observational studies found that individuals with obesity showed a lower incidence and fatality than did those with underweight among patients with sepsis. These discrepancies may stem from methodological limitations in observational research, such as residual confounding and reverse causality. For instance, sepsis-induced systemic inflammation could transiently alter metabolic markers, obscuring true causal directions.

The core idea of Mendelian randomization (MR) is to use genetic variants (typically single-nucleotide polymorphisms [SNPs]) as instrumental variables to infer whether a potential causal association exists between an exposure and a health outcome. Recent MR studies have explored individual factors such as obesity, diabetes mellitus, and lipid profiles in patients with sepsis [19-23]; however, critical gaps persist. First, lifestyle factors (eg, smoking and diet) remain understudied despite their clinical relevance. Second, the existing MR analyses of sepsis predominantly examine isolated risk factors, neglecting potential synergies between socioeconomic, metabolic, and behavioral determinants [8,9,24-28]. Third, the interaction between modifiable factors and genetic predisposition remains unexplored, limiting personalized preventive strategies.

To address these gaps, we conducted a comprehensive 2-sample MR analysis of 30 modifiable factors spanning lifestyle, socioeconomic status, and metabolic health. This approach not only circumvents confounding biases but also systematically evaluates multifactorial contributions to sepsis pathogenesis. Our findings aimed to clarify controversial associations in prior literature and prioritize actionable targets for intervention.


MR Design

MR is based on three key assumptions: genetic variants are (1) linked to risk factors, (2) independent of confounding factors, and (3) influence outcomes solely through risk factors (Figure 1). A total of 30 prominent modifiable risk factors were included and grouped into lifestyle and metabolic factors. This study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomization (STROBE-MR) guidelines. Initially, we screened instrumental variables for MR analysis using lifestyle factors and metabolic comorbidities as “exposures” and sepsis as “outcomes.” Subsequently, we conducted a reverse MR analysis, with sepsis as the “exposure” and lifestyle and metabolic factors as the “outcomes.”

Figure 1. Overview of the design and methods used in this Mendelian randomization (MR) study. MR analysis was used to explore the causal relationships, including the following groups: lifestyles and metabolic factors. Solid arrows represent causal effects, and dashed arrows and crosses represent causal effects prohibited by MR assumptions II and III. HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; T2DM: type 2 diabetes mellitus.

Data Sources

Genome-wide association study (GWAS) data of sepsis were obtained from the OpenGWAS database, a dataset published by the UK Biobank in 2021, comprising a sample of 486,484 participants from European populations. Additionally, we used 30 parameters from the Integrative Epidemiology Unit OpenGWAS Project as our lifestyle, education and psychology, and metabolic traits. Data are listed in Table 1.

Table 1. Characteristics of the genome‐wide association study (GWAS) summary data in this study.
ExposureEthnicityGWAS IDTotal population, nSNPsa, n
Diet
Alcohol consumptionEuropeanieu-b-73335,39411,887,865
Coffee consumptionEuropeanukb-b-5237428,8609,851,867
Milk consumptionSouth Asianukb-e-100520_CSA14699,797,409
Sweets consumptionAfrican Americanukb-e-102330_AFR120715,533,528
Smoking
Smoking initiationEuropeanieu-b-4877607,29111,802,365
Age of smokingEuropeanieu-b-24341,42711,894,779
Number of cigarettes dailyEuropeanukb-b-6019108,9469,851,867
Physical activity
Light activityEuropeanukb-b-11495460,3769,851,867
Moderate to vigorousEuropeanebi-a-GCST006097377,23411,808,007
Sleep habit
InsomniaEuropeanukb-b-3957462,3419,851,867
Nap during dayEuropeanukb-b-4616462,4009,851,867
Sleep durationEuropeanukb-b-4424460,0999,851,867
Physical and mental
Unhealthy emotionsEuropeanukb-b-6991459,5609,851,867
Overall health ratingEuropeanukb-b-16489458,0799,851,867
College or universityEuropeanukb-b-6306460,8449,851,867
Blood lipid traits
TriglyceridesEuropeanieu-b-485078,7007,892,037
Total cholesterolEuropeanmet-d-Total_C115,07812,321,875
HDL‐cbEuropeanmet-d-HDL_C115,07812,321,875
LDL‐ccEuropeanie,u-b-110440,54612,321,875
Obesity traits
BMIEuropeanukb-b-19953461,4609,851,867
Waist circumferenceEuropeanukb-b-9405462,1669,851,867
Whole body fat massEuropeanukb-b-19393454,1379,851,867
Trunk fat massEuropeanukb-b-20044454,5889,851,867
Arm fat mass (left)Europeanukb-b-8338454,6849,851,867
Leg fat mass (left)Europeanukb-b-7212454,8239,851,867
Metabolic syndrome
T2DMdEuropeanebi-a-GCST010118433,54011,222,507
HypertensionEuropeanfinn-b-I9_HYPTENS162,83716,380,466
Cardiovascular diseasesEuropeanfinn-b-I9_CVD107,68416,380,466
Ischemic strokeEuropeanebi-a-GCST006908440,3288,296,492
Percent liver fatEuropeanebi-a-GCST9001667332,8589,275,407

aSNP: single-nucleotide polymorphism.

bHDL‐C: high-density lipoprotein cholesterol.

cLDL‐C: low-density lipoprotein cholesterol.

dT2DM: type 2 diabetes mellitus.

Selection of Genetic Variants

In this MR analysis, instrumental variables were used to investigate the association between potentially modifiable risk factors and sepsis. These risk traits were categorized into three main parts: (1) lifestyle factors encompassing 4 dietary traits, 3 smoking-related traits, 2 pertaining to physical activity, and 3 regarding sleep habits; (2) educational and psychological factors, including physical and mental well-being and education level; and (3) metabolic factors comprising 4 traits linked to blood lipid parameters, 6 associated with obesity traits, and 5 related to metabolic comorbidities. SNPs were selected as independent genetic predictors based on the following criteria: first, a genome-wide significance threshold of P<5×10−8 was applied. If there were insufficient significant SNPs under this threshold, a threshold of P<1×10−5 was used. Second, the clump function was used to test for linkage disequilibrium with a threshold of R2<0.001 and a distance of 10,000 kb. Third, SNPs related to outcomes were excluded using the linkage disequilibrium link database to avoid confounding factors. Fourth, SNPs with an F statistic <10 were excluded to avoid bias from weak instruments. The proportion of exposure variance explained by genetic instruments (R2) was calculated to quantify the strength of the genetic tools. The F statistic for each SNP was calculated to assess the strength of the selected instruments.

Ethical Considerations

This study is a secondary analysis of publicly available GWAS summary statistics obtained from the Integrative Epidemiology Unit OpenGWAS database [29] as shown in Table 1. These datasets consist of deidentified data from participant studies approved by an ethics committee concerning human experimentation, comply with the ethical principles of the Declaration of Helsinki, and were approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang University (2025B-1097).

Statistical Analysis

In this study, all analyses were performed using the TwoSampleMR package in R (version 4.2.1; R Foundation for Statistical Computing). The random-effects inverse variance weighted (IVW) method was used as the primary outcome; this method assumed that all instrumental variables (SNPs) were valid instruments (ie, satisfying the exclusion restriction assumption) and estimated the causal effect between exposure and outcome by calculating the weighted regression slope of the SNP-outcome associations on the SNP-exposure associations. Although the IVW approach offered the highest statistical power among MR methods, it was sensitive to directional pleiotropy, which might have biased causal estimates if invalid SNPs were present. Therefore, the MR-Egger and weighted median methods were used to refine the IVW estimation. These alternative methods offered more dependable estimates across a broader spectrum of scenarios, albeit with a trade-off of reduced efficiency, resulting in wider CIs. MR-Egger permitted all genetic variants to exhibit pleiotropy; however, pleiotropy must be independent of variant exposure associations. Meanwhile, the weighted median method allowed the incorporation of potentially invalid instrumental variables under the assumption that at least half of the instruments used in the MR analysis were valid. We performed reverse MR analyses by swapping the roles of the original exposure and outcome variables; IVW analysis tests were conducted using the same set of SNPs.

Heterogeneity was evaluated using the Cochran Q analysis. Sensitivity analyses were conducted using MR-Egger regression intercept tests and leave-one-out analyses, with statistical significance set at P<.05. Additionally, multivariable MR analyses were performed to adjust for the genetic association of the instruments with the BMI.


Baseline Characteristics

We assessed 30 potentially modifiable risk factors to investigate their causal associations with sepsis and categorized them into 3 groups (Table 1): lifestyle, educational and psychological, and metabolic factors. The number of SNPs ranged between 7,892,037 and 15,533,528 (Table 1). Notably, the F statistics for all considered traits exceeded 10, indicating the absence of a potential weak instrumental bias.

Lifestyle Factors

Regarding the investigation of lifestyle factors, our findings revealed that genetically predicted smoking initiation (odds ratio [OR] 1.20, 95% CI 1.06‐1.36; P=.005) and a higher number of cigarettes smoked daily (OR 1.70, 95% CI 1.29‐2.23; P<.001) were associated with an increased risk of sepsis. Conversely, genetically predicted light physical activity (OR 0.26, 95% CI 0.08‐0.83; P=.02) was associated with a decreased risk of sepsis. These results remained consistent across the random-effects IVW and weighted median analyses (Table 2). Notably, no significant causal association was detected between genetically predicted alcohol, coffee, milk, and sweet consumptions; age at smoking; moderate to vigorous physical activity; insomnia; daytime napping; sleep duration; and sepsis (all P>.05). We did not find statistically significant results when investigating reverse causality validation (P>.05).

Table 2. Mendelian randomization (MR) estimates for the causal effect of modifiable lifestyle and metabolic factors on sepsis.
ExposureSNPsa, nIVWb,
ORc (95% CI)
P valueWMd,
OR (95% CI)
P valueMR-Egger,
OR (95% CI)
P valueCochran Q–derived P valueMR-Egger intercept–derived P value
Diet
Alcohol consumption351.00 (0.76‐1.32).991.04 (0.69‐1.57).851.02 (0.64‐1.61).94.34.92
Coffee consumption391.14 (0.79‐1.64).481.10 (0.71‐1.71).670.88 (0.42‐1.83).73.06.43
Milk consumption50.97 (0.92‐1.03).290.95 (0.89‐1.02).191.29 (0.73‐2.28).45.71.40
Sweets consumption110.99 (0.97‐1.01).470.99 (0.97‐1.02).641.05 (0.99‐1.11).110.25.06
Smoking
Smoking initiation861.20 (1.06‐1.36).0051.22 (1.02‐1.47).0341.72 (0.90‐3.28).10.41.27
Age of smoking70.89 (0.46‐1.71).7231.25 (0.56‐2.79).590.32 (0.04‐2.68).34.28.37
Number of cigarettes daily61.70 (1.29‐2.23)<.0011.72 (1.25‐2.36)<.0012.30 (1.31‐4.04).04.86.29
Physical activity
Light activity120.26 (0.08‐0.83).030.12 (0.03‐0.58).0071.12 (0.02‐78.84).96.74.50
Moderate to vigorous190.98 (0.61‐1.57).921.10 (0.58‐2.06).780.27 (0.03‐2.58).27.68.27
Sleep habit
Insomnia381.08 (0.63‐1.87).771.02 (0.50‐2.07).950.52 (0.09‐2.94).46.02.39
Nap during day881.04 (0.74‐1.45).840.93 (0.55‐1.57).791.45 (0.46‐4.55).53.45.55
Sleep duration650.80 (0.57‐1.11).190.83 (0.50‐1.36).451.17 (0.32‐4.32).81.27.55
Physical and mental
Unhealthy emotions411.36 (0.67‐2.74).401.22 (0.45‐3.30).700.48 (0.01‐22.66).71.81.59
Overall health rating1062.19 (1.61‐2.98)<.0011.63 (1.09‐2.44).022.33 (0.49‐11.00).29.02.94
College or university2420.52 (0.40‐0.67)<.0010.55 (0.37‐0.82).0030.52 (0.18‐1.51).23.85.97
Blood lipid traits
Triglycerides381.00 (0.89‐1.13).941.02 (0.88‐1.18).801.14 (0.91‐1.42).25.008.20
Total cholesterol3590.97 (0.89‐1.05).470.98 (0.87‐1.10).701.00 (0.88‐1.14).99.02.51
HDL‐ce910.91 (0.84‐0.98).020.89 (0.79‐0.99).040.86 (0.76‐0.98).02.01.33
LDL‐cf1731.05 (0.97‐1.13).221.06 (0.93‐1.20).361.08 (0.97‐1.21).17.39.45
Obesity traits
BMI4321.50 (1.38‐1.63)<.0011.47 (1.25‐1.72)<.0011.47 (1.17‐1.85)<.001.21.85
Waist circumference3571.70 (1.53‐1.89)<.0011.64 (1.36‐1.98)<.0011.52 (1.12‐2.05).008.32.43
Whole body fat mass4121.50 (1.37‐1.64)<.0011.51 (1.31‐1.75)<.0011.50 (1.16‐1.93).002.05.99
Trunk fat mass3991.48 (1.36‐1.62)<.0011.51 (1.31‐1.75)<.0011.02 (1.31‐1.68).03.08.29
Arm fat mass (left)4021.57 (1.43‐1.71)<.0011.52 (1.30‐1.77)<.0011.57 (1.22‐2.00)<.001.14.99
Leg fat mass (left)3971.69 (1.51-1.90)<.0011.65 (1.37-1.99)<.0011.34 (1.83-2.53)<.001.11.59
Metabolic syndrome
T2DMg1481.03 (0.99‐1.07).161.05 (0.98‐1.11).141.07 (0.99‐1.15).11.11.31
Hypertension551.00 (0.94‐1.06).980.97 (0.90‐1.06).560.86 (0.70‐1.05).15.52.13
Cardiovascular diseases91.09 (0.91‐1.32).350.96 (0.75‐1.22).750.52 (0.21‐1.32).21.66.16
Ischemic stroke81.02 (0.88‐1.18).780.99 (0.82‐1.19).901.10 (0.37‐3.24).87.81.90
Percent liver fat101.02 (0.93‐1.11).661.02 (0.91‐1.13).760.96 (0.84‐1.10).59.56.30

aSNP: single-nucleotide polymorphism.

bIVW: inverse variance weighted.

cOR: odds ratio.

dWM: weighted median.

eHDL‐c: high‐density lipoprotein cholesterol.

fLDL‐c: low-density lipoprotein cholesterol.

gT2DM: type 2 diabetes mellitus.

Educational and Psychological Factors

Considering the investigation of educational and psychological factors, we found that genetically predicted higher overall health rating (OR 2.19, 95% CI 1.61‐2.98; P<.001) was associated with an increased risk of sepsis (Table 2). Conversely, genetically predicted higher education attainment (individuals with a college or university degree; OR 0.52, 95% CI 0.40‐0.67; P<.001) was associated with decreased risk of sepsis. Notably, no significant causal association was found between genetically driven unhealthy emotions and sepsis (P=.40). We did not find statistically significant results when investigating reverse causality validation (P>.05).

Metabolic Factors

We found an increased risk of sepsis associated with genetically predicted obesity. All fat mass–related traits were significantly associated with an increased risk of sepsis. The odds of developing sepsis increased with every 1‐SD increment in the BMI (OR 1.50, 95% CI 1.38‐1.63; P<.001), waist circumference (OR 1.70, 95% CI 1.53‐1.89; P<.001), whole body fat mass (OR 1.50, 95% CI 1.37‐1.64; P<.001), trunk fat mass (OR 1.48, 95% CI 1.36‐1.62; P<.001), arm fat mass (left; OR 1.57, 95% CI 1.43‐1.71; P<.001), and leg fat mass (left; OR 1.69, 95% CI 1.51‐1.90; P<.001; Table 2). However, high-density lipoprotein cholesterol (HDL-C; OR 0.91, 95% CI 0.84‐0.98; P=.02) exhibited a protective effect against sepsis. In contrast, no significant causal association was observed between genetically predicted triglycerides, total cholesterol, low-density lipoprotein cholesterol, type 2 diabetes mellitus, hypertension, cardiovascular diseases, ischemic stroke, percent liver fat, and sepsis (all P>.05).

Reverse MR Analysis

To validate the reliability of the exposure-outcome causal direction, we performed reverse MR analysis by swapping the roles of the original exposure and outcome variables, and IVW analysis tests were conducted using the same set of SNPs. We did not find statistically significant results when investigating reverse causality validation (P>.05).

Multivariable MR Analysis

Considering the mutual influence of various obesity indicators, we conducted a multivariate MR analysis of BMI, waist circumference, whole body fat mass, trunk fat mass, arm fat mass (left), and leg fat mass (left). The results revealed that the waist circumference (OR 2.16, 95% CI 1.18‐3.96; P=.01) was an independent risk factor of sepsis (Figure 2).

Figure 2. The association between obesity traits (BMI, waist circumference, whole body fat mass, trunk fat mass, arm fat mass, and leg fat mass) and sepsis by multivariable Mendelian randomization. Odds ratios (ORs) represent the associations with sepsis.

Heterogeneity and Pleiotropy Test

Although some results displayed heterogeneity based on the Cochran Q test (P>.05), the use of random-effects IVW as the primary outcome rendered this heterogeneity acceptable and did not undermine the validity of the MR estimates in this study (Table 2). In addition, the results were subjected to pleiotropy testing, demonstrating that those with significance did not exhibit pleiotropy. Therefore, assuming the absence of horizontal pleiotropy in this study is reasonable.

Sensitivity Analysis

We conducted a sensitivity analysis using the MR-Egger intercept tests and the leave-one-out method. MR-Egger intercept tests showed no evidence of pleiotropy (Table 2). Using leave-one-out analysis, it is evident that nearly all lines align on one side of the y-axis, with minimal deviation beyond the axis. This consistency indicated the robustness of the results. The stable results shown in the MR visualization further corroborate the reliability of our study findings.


In this bidirectional MR study, we investigated the association of lifestyle, educational and psychological, and metabolic factors with the risk of sepsis. Genetic variants such as smoking initiation, smoking frequency, and waist circumference were associated with an increased risk of sepsis, whereas light physical activity, higher education, and high levels of HDL-c were causally associated with a lower risk of sepsis (Figure 3).

Figure 3. Association of modifiable lifestyle and metabolic factors with the risk of developing sepsis. HDL-C: high-density lipoprotein cholesterol; MR: Mendelian randomization.

Genetic variants such as smoking initiation, smoking frequency, and waist circumference were associated with an increased risk of sepsis, whereas light physical activity, higher education, and high levels of HDL-c were causally associated with a lower risk of sepsis.

Owing to the modifiable nature of lifestyle, the impact of lifestyle on diseases with high mortality, such as sepsis, has received increasing attention. Numerous observational studies have described an association between smoking, alcohol consumption, and the risk of various infectious diseases [22,30-35]. However, establishing a causal link between lifestyle and sepsis remains challenging. This study aimed to explore the potential causal relationships between lifestyle factors and sepsis. The results showed that smoking initiation and a high frequency of smoking were associated with an increased risk of sepsis. Previous immunologic experiments reported that smoking has been associated with impaired phagocytic function and cytokine expression of T lymphocytes and macrophages in the respiratory tract or peripheral blood [36-38]. These studies collectively underscore the detrimental impact of smoking on the immune system. These findings provide a better understanding of the role of smoking in patients with sepsis. Therefore, healthy lifestyle modification is a preventive measure against sepsis; individuals should be advised to reduce smoking to reduce the risk of developing sepsis.

Physical exercise is a planned, purposeful action to maintain a healthy lifestyle and improve physical fitness (World Health Organization, 2010) [39]. Furthermore, the evidence suggests that physical exercise affects multiple organ systems under various conditions [40]. It has been found that inadequate exercise is associated with a doubled risk of sepsis-related mortality [40]. Given that the incidence of sepsis is increasing, these results suggest that exercising could be immediately effective in reducing disease incidence. Currently, no MR analyses of the association between physical activity and sepsis are available. Our analysis confirmed that light physical activity is associated with a lower risk of sepsis.

The socioeconomic status affects health through environmental exposure, health behaviors, and lifestyle and has been shown to be positively related to health [10,41]. Education stands as the most potent indicator of socioeconomic status, exerting influence over lifestyle choices and access to health resources [42]. Observational studies suggest an inverse association between educational attainment and sepsis risk. Wang et al [43] reported significantly higher sepsis risk among individuals with lower education (hazard ratio 1.88, 95% CI 1.54‐2.29), though without controlling for comorbidities and other confounders. Another cohort study adjusting for socioeconomic factors still demonstrated a higher risk of sepsis-related intensive care unit admission in moderately educated versus highly educated individuals [44]. It should be noted that these observational findings may be influenced by residual confounding and do not establish causality. This study found a negative correlation between genetically predicted educational levels and sepsis risk. Higher education may reduce sepsis risk through multiple pathways, including enhanced health literacy (eg, earlier recognition of infections), greater access to health care resources, and adoption of healthier behaviors (eg, smoking cessation and improved diet). These mechanisms could collectively mitigate exposure to risk factors and improve timely medical intervention.

In recent years, an increasing number of studies have focused on the impact of metabolic factors such as blood glucose, blood lipids, and obesity on various infectious diseases [45-49]. Previous studies have reported that high HDL-c levels are significantly associated with reduced sepsis risk and other sepsis-related outcomes [50,51]. Extremely low serum HDL-c levels (≤20 mg/dL) are associated with an increased risk of death, sepsis, and malignancy [52]. However, observational clinical and epidemiologic studies have potential problems such as confounding, reverse causation, and unaccounted comorbidities. An MR study found that lower HDL-c levels were significantly associated with an increased risk of sepsis and related outcomes in infected patients [53]. This is consistent with our findings. Our study found a genetic relationship between high HDL-c levels and low risk of sepsis. HDL-c might exert protective effects against sepsis via its anti-inflammatory and antioxidant properties, as well as its role in modulating endothelial function and neutralizing bacterial endotoxins [54-56].

In observational studies on the general population, a higher BMI has been associated with an increased incidence of mortality from bloodstream infections and sepsis [57-59]. This finding is confirmed in this study. We also found that BMI, arm fat mass, leg fat mass, whole body fat mass, waist circumference, and trunk fat mass were significantly associated with sepsis. However, using the multivariate factor analysis, only increased waist circumference was an independent risk factor for sepsis, which might be because other factors included the causes of increased waist circumference, suggesting that these factors might influence sepsis risk as a consequence of shared risk factor profiles.

This study had several limitations. First, the population limited to the European ancestry hampered the generalization of the findings to individuals of other ancestries, as genetic and environmental factors influencing sepsis risk may vary across ethnic groups (eg, differences in inflammatory responses or health care access). Further studies are required to assess the modifiable risk of sepsis in other races. Second, as with all MR studies, pleiotropy in an MR setting is challenging. Additionally, gene-environment interactions (eg, how lifestyle modifies genetic risk) and potential measurement errors in exposure variables were not fully addressed, which might have introduced bias. We performed various sensitivity analyses that made different assumptions regarding the underlying nature of pleiotropy. Most tests showed stable results. Future studies should incorporate multi-ancestry cohorts and explore gene-environment interplay to strengthen causal inference.

In conclusion, our combined MR analysis supports the causal roles of smoking, educational level, HDL-c level, physical condition, obesity, and physical activity in patients with sepsis. The findings of this study highlight actionable targets for sepsis prevention. For instance, smoking cessation programs, public health initiatives to promote physical activity, and interventions to improve HDL-c levels (eg, dietary modifications or pharmacotherapy) could be integrated into personalized preventive strategies for managing high-risk populations. Furthermore, educational campaigns targeting health literacy and early symptom recognition might reduce delays in seeking care, particularly among socioeconomically disadvantaged groups. Future research should prioritize replication in diverse populations, mechanistic studies to elucidate pathways (eg, HDL-c’s immunomodulatory effects), and translational interventions targeting high-risk subgroups.

Acknowledgments

The authors would like to acknowledge the participants and investigators of the Integrative Epidemiology Unit OpenGWAS project used in this paper.

Data Availability

Publicly available datasets were analyzed in this Mendelian randomization study. Genome-wide association study summary-level datasets were downloaded from the Integrative Epidemiology Unit OpenGWAS Project [29]. Full details are provided in Table 1.

Authors' Contributions

Data curation: HL, JL

Formal analysis: HL, JL

Methodology: YC

Project administration: KX

Software: HL, JL

Supervision: XW, KX

Validation: GS, FW, QY

Visualization: HL, JL, WF

Writing–original draft: HL, JL, YC, KX, XW, GS, FW, QY, WF

Writing–review and editing: HL, JL, YC, KX, XW, GS, FW, QY, WF

Conflicts of Interest

None declared.

Checklist 1

STROBE-MR checklist.

DOCX File, 31 KB

  1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. Feb 23, 2016;315(8):801-810. [CrossRef] [Medline]
  2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. Jan 18, 2020;395(10219):200-211. [CrossRef] [Medline]
  3. Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. Mar 2020;48(3):e209-e218. [CrossRef] [Medline]
  4. Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. World Health Organization; 2020. URL: https://www.who.int/publications/i/item/ 9789240010789 [Accessed 2025-10-23]
  5. Vincent JL, van der Poll T, Marshall JC. The end of “one size fits all” sepsis therapies: toward an individualized approach. Biomedicines. Sep 12, 2022;10(9):2260. [CrossRef] [Medline]
  6. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. Nov 2021;47(11):1181-1247. [CrossRef] [Medline]
  7. Vincent JL. Emerging paradigms in sepsis. EBioMedicine. Dec 2022;86:104398. [CrossRef] [Medline]
  8. Rubio I, Osuchowski MF, Shankar-Hari M, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. Dec 2019;19(12):e422-e436. [CrossRef]
  9. Wiewel MA, Harmon MB, van Vught LA, et al. Risk factors, host response and outcome of hypothermic sepsis. Crit Care. Oct 14, 2016;20(1):328. [CrossRef] [Medline]
  10. Stensrud VH, Gustad LT, Damås JK, Solligård E, Krokstad S, Nilsen TIL. Direct and indirect effects of socioeconomic status on sepsis risk and mortality: a mediation analysis of the HUNT study. J Epidemiol Community Health. Mar 2023;77(3):168-174. [CrossRef] [Medline]
  11. Rose N, Matthäus-Krämer C, Schwarzkopf D, et al. Association between sepsis incidence and regional socioeconomic deprivation and health care capacity in Germany - an ecological study. BMC Public Health. Sep 7, 2021;21(1):1636. [CrossRef] [Medline]
  12. Trevelin SC, Carlos D, Beretta M, da Silva JS, Cunha FQ. Diabetes mellitus and sepsis: a challenging association. Shock. Mar 2017;47(3):276-287. [CrossRef] [Medline]
  13. Ahlberg CD, Wallam S, Tirba LA, Itumba SN, Gorman L, Galiatsatos P. Linking Sepsis with chronic arterial hypertension, diabetes mellitus, and socioeconomic factors in the United States: a scoping review. J Crit Care. Oct 2023;77:154324. [CrossRef] [Medline]
  14. Stösser S, Kleusch L, Schenk A, Schmid M, Petzold GC. Derivation and validation of a screening tool for stroke-associated sepsis. Neurol Res Pract. Jul 13, 2023;5(1):32. [CrossRef] [Medline]
  15. Hou J, Zhang J, Cui P, et al. TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis. J Clin Invest. Feb 15, 2021;131(4):e135197. [CrossRef] [Medline]
  16. You J, Bi X, Zhang K, et al. Causal associations between gut microbiota and sepsis: a two-sample Mendelian randomization study. Eur J Clin Invest. Nov 2023;53(11):e14064. [CrossRef] [Medline]
  17. Wang GS, You KM, Jo YH, et al. Association of health insurance status with outcomes of sepsis in adult patients: a retrospective cohort study. Int J Environ Res Public Health. May 27, 2021;18(11):5777. [CrossRef] [Medline]
  18. Frydrych LM, Bian G, O’Lone DE, Ward PA, Delano MJ. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. Sep 2018;104(3):525-534. [CrossRef] [Medline]
  19. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. [CrossRef]
  20. Lei P, Xu W, Wang C, Lin G, Yu S, Guo Y. Mendelian randomization analysis reveals causal associations of polyunsaturated fatty acids with sepsis and mortality risk. Infect Dis Ther. Jul 2023;12(7):1797-1808. [CrossRef] [Medline]
  21. Wang J, Hu Y, Zeng J, et al. Exploring the causality between body mass index and sepsis: a two-sample Mendelian randomization study. Int J Public Health. 2023;68:1605548. [CrossRef] [Medline]
  22. Zhu H, Zhan X, Wang C, et al. Causal associations between tobacco, alcohol use and risk of infectious diseases: a Mendelian randomization study. Infect Dis Ther. Mar 2023;12(3):965-977. [CrossRef] [Medline]
  23. Hu J, Gan Q, Zhou D, et al. Evaluating the risk of sepsis attributing to obesity: a two-sample Mendelian randomization study. Postgrad Med J. Nov 20, 2023;99(1178):1266-1271. [CrossRef] [Medline]
  24. Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186. [CrossRef] [Medline]
  25. Thorkildsen MS, Gustad LT, Mohus RM, et al. Association of genetically predicted insomnia with risk of sepsis: a Mendelian randomization study. JAMA Psychiatry. Oct 1, 2023;80(10):1061-1065. [CrossRef] [Medline]
  26. Ni F, Liu X, Wang S. Impact of negative emotions and insomnia on sepsis: a mediation Mendelian randomization study. Comput Biol Med. Sep 2024;180:108858. [CrossRef] [Medline]
  27. Shang W, Qian H, Zhang S, et al. Human blood metabolites and risk of sepsis: a Mendelian randomization investigation. Eur J Clin Invest. Apr 2024;54(4):e14145. [CrossRef] [Medline]
  28. Zhu ZG, Ma JW, Ji DD, Li QQ, Diao XY, Bao J. Mendelian randomization analysis identifies causal associations between serum lipidomic profile, amino acid biomarkers and sepsis. Heliyon. Jun 30, 2024;10(12):e32779. [CrossRef] [Medline]
  29. OpenGWAS. URL: https://opengwas.io/ [Accessed 2025-10-28]
  30. O’Brien JM Jr, Lu B, Ali NA, et al. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med. Feb 2007;35(2):345-350. [CrossRef] [Medline]
  31. Bello S, Menéndez R, Antoni T, et al. Tobacco smoking increases the risk for death from pneumococcal pneumonia. Chest. Oct 2014;146(4):1029-1037. [CrossRef] [Medline]
  32. Gustot T, Fernandez J, Szabo G, et al. Sepsis in alcohol-related liver disease. J Hepatol. Nov 2017;67(5):1031-1050. [CrossRef] [Medline]
  33. Bukong TN, Cho Y, Iracheta-Vellve A, et al. Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use. J Hepatol. Nov 2018;69(5):1145-1154. [CrossRef] [Medline]
  34. Moazed F, Hendrickson C, Jauregui A, et al. Cigarette smoke exposure and acute respiratory distress syndrome in sepsis: epidemiology, clinical features, and biologic markers. Am J Respir Crit Care Med. Apr 15, 2022;205(8):927-935. [CrossRef] [Medline]
  35. Sabaratnam R, Wojtaszewski JFP, Højlund K. Factors mediating exercise-induced organ crosstalk. Acta Physiol (Oxf). Feb 2022;234(2):e13766. [CrossRef] [Medline]
  36. Burton R, Fryers PT, Sharpe C, et al. The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations. Public Health. Jan 2024;226:39-52. [CrossRef] [Medline]
  37. Lee EH, Lee KH, Lee KN, Park Y, Do Han K, Han SH. The relation between cigarette smoking and development of sepsis: a 10-year follow-up study of four million adults from the national health screening program. J Epidemiol Glob Health. Jun 2024;14(2):444-452. [CrossRef] [Medline]
  38. Elisia I, Lam V, Cho B, et al. The effect of smoking on chronic inflammation, immune function and blood cell composition. Sci Rep. Nov 10, 2020;10(1):19480. [CrossRef] [Medline]
  39. Ye KX, Sun L, Wang L, et al. The role of lifestyle factors in cognitive health and dementia in oldest-old: a systematic review. Neurosci Biobehav Rev. Sep 2023;152:105286. [CrossRef] [Medline]
  40. Williams PT. Inadequate exercise as a risk factor for sepsis mortality. PLoS One. 2013;8(12):e79344. [CrossRef] [Medline]
  41. Minejima E, Wong-Beringer A. Impact of socioeconomic status and race on sepsis epidemiology and outcomes. J Appl Lab Med. Jan 12, 2021;6(1):194-209. [CrossRef] [Medline]
  42. Rosengren A, Smyth A, Rangarajan S, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. Jun 2019;7(6):e748-e760. [CrossRef] [Medline]
  43. Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, Howard G. Chronic medical conditions and risk of sepsis. PLoS One. 2012;7(10):e48307. [CrossRef] [Medline]
  44. Storm L, Schnegelsberg A, Mackenhauer J, Andersen LW, Jessen MK, Kirkegaard H. Socioeconomic status and risk of intensive care unit admission with sepsis. Acta Anaesthesiol Scand. Aug 2018;62(7):983-992. [CrossRef] [Medline]
  45. Madsen CM, Varbo A, Tybjærg-Hansen A, Frikke-Schmidt R, Nordestgaard BG. U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies. Eur Heart J. Apr 7, 2018;39(14):1181-1190. [CrossRef] [Medline]
  46. Meng J, Li X, Xiao Y, et al. Intensive or liberal glucose control in intensive care units for septic patients? A meta-analysis of randomized controlled trials. Diabetes Metab Syndr. May 2024;18(5):103045. [CrossRef] [Medline]
  47. Liu P, Meng J, Tang H, et al. Association between bariatric surgery and outcomes of total joint arthroplasty: a meta-analysis. Int J Surg. 2025;111(1):1541-1546. [CrossRef]
  48. Meng J, Li X, Liu W, et al. The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: a meta-analysis of randomized controlled trials. Clin Nutr. Nov 2023;42(11):2198-2206. [CrossRef] [Medline]
  49. Meng J, Li X, Xiong Y, Wu Y, Liu P, Gao S. The role of vitamin D in the prevention and treatment of tuberculosis: a meta-analysis of randomized controlled trials. Infection. Jun 2025;53(3):1129-1140. [CrossRef]
  50. Scalsky RJ, Chen YJ, Desai K, O’Connell JR, Perry JA, Hong CC. Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank. PLoS ONE. 2021;16(4):e0248602. [CrossRef]
  51. Shor R, Wainstein J, Oz D, et al. Low HDL levels and the risk of death, sepsis and malignancy. Clin Res Cardiol. Apr 2008;97(4):227-233. [CrossRef]
  52. Liu G, Jiang L, Kerchberger VE, et al. The relationship between high density lipoprotein cholesterol and sepsis: a clinical and genetic approach. Clinical Translational Sci. Mar 2023;16(3):489-501. [CrossRef]
  53. Twig G, Geva N, Levine H, et al. Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents. Int J Obes (Lond). Apr 2018;42(4):801-807. [CrossRef] [Medline]
  54. Hamilton F, Pedersen KM, Ghazal P, Nordestgaard BG, Smith GD. Low levels of small HDL particles predict but do not influence risk of sepsis. Crit Care. Oct 9, 2023;27(1):389. [CrossRef] [Medline]
  55. Taylor R, Zhang C, George D, et al. Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies. EBioMedicine. Feb 2024;100:104981. [CrossRef] [Medline]
  56. Zou G, Zhu Q, Ren B, et al. HDL-associated lipoproteins: potential prognostic biomarkers for gram-negative sepsis. J Inflamm Res. 2022;15:1117-1131. [CrossRef] [Medline]
  57. Weng L, Fan J, Yu C, et al. Body-mass index and long-term risk of sepsis-related mortality: a population-based cohort study of 0.5 million Chinese adults. Crit Care. Aug 31, 2020;24(1):534. [CrossRef] [Medline]
  58. Paulsen J, Askim Å, Mohus RM, et al. Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: a 15-year follow-up of 64 027 individuals in the HUNT Study. Int J Epidemiol. Oct 1, 2017;46(5):1573-1581. [CrossRef] [Medline]
  59. Winter-Jensen M, Afzal S, Jess T, Nordestgaard BG, Allin KH. Body mass index and risk of infections: a Mendelian randomization study of 101,447 individuals. Eur J Epidemiol. Apr 2020;35(4):347-354. [CrossRef] [Medline]


GWAS: genome-wide association study
HDL-C: high-density lipoprotein cholesterol
IVW: inverse variance weighted
MR: Mendelian randomization
OR: odds ratio
SNP: single-nucleotide polymorphism
STROBE-MR: Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomization


Edited by Naomi Cahill; submitted 06.Feb.2025; peer-reviewed by Binsheng He, Ogochukwu Abasilim; final revised version received 01.Oct.2025; accepted 01.Oct.2025; published 03.Nov.2025.

Copyright

© Haifeng Lv, Jing Liu, Yelin Cao, Weina Fan, Guojie Shen, Feifei Wang, Qingqing Ye, Xiaoliang Wu, Kaijin Xu. Originally published in the Interactive Journal of Medical Research (https://www.i-jmr.org/), 3.Nov.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Interactive Journal of Medical Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.i-jmr.org/, as well as this copyright and license information must be included.